Vaccines & Immunotherapies

Online Symposium

26 September 2024 | Online, BST (UTC+1)

Bringing together key opinion leaders from across the globe for focused discussions on modern vaccine technologies & development

Key Topics Covered

  • Modern vaccine technologies:
       » mRNA
  • Advances in vaccine delivery systems and routes of administration:
       » LNP delivery
  • Addressing vaccine stability and cold chain reduction strategies
  • Case studies in vaccine development for cancer and infectious diseases

Benefits of Attending

  • Meet with global key innovators in a focused symposium to hear the latest case studies in vaccines & immunotherapies. This programme takes a deep dive into best practice vaccine development approaches & technological advancements, bringing together thought leaders from across the globe for focused discussions & networking
  • Take a deep dive into immunotherapy strategies for cancer and autoimmune diseases. Delve into the latest innovations in cancer immunotherapy, including the discovery of new targets, as well as immunomodulatory vaccines for autoimmune disease care
  • Gain a comprehensive understanding of vaccine delivery systems & adjuvant production. From advances in vaccine administration through to modes of action and regulatory considerations
  • Followed by the release of the ‘Harnessing Vaccine Technologies & Immunotherapies with Best Practice Approaches’ report detailing key insights, methodologies, and emerging trends discussed during the event for leveraging vaccines and immunotherapies effectively

Latest Resources

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

GHR’s total investment in C2N has now broken $50 million since 2020.

Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality

The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.

Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy

SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.

Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma

The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.

Life Science Players Join €23m European Project for Precision Medicine, PRECISEU

The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.

Meet Our Expert Speakers

Vaccines & Immunotherapies Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Confirmed speakers include:

Amita Vaidya
Principal Scientist,
Sanofi
Brian Schanen
Global Head,
Sanofi
Eric Halioua
Chief Executive Officer,
PDC* Line Pharma
Mabrouka Maamra
Project Manager,
University of Sheffield
Mats Lundgren
CSO,
Abera Bioscience
Ola Nilsson
Head of Neoantigen Production & Development,
NEOGAP Therapeutics AB
Samantha Paston
Head of translational research,
Scancell ltd
Tobias von der Haar
Professor of Systems Biology,
University of Kent

Register Your Interest

Submit your details and a member of our team will be in touch